Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | BRD2 | P25440 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21278138 | 0.88 | PIK3CD (0.41) | SMN1; SMN2CYP2D6CYP2C9CHRM2CHRM4 | |
| SCHEMBL718764 | 0.88 | PIK3CD (0.41) | SMN1; SMN2CYP2D6CYP2C9CHRM2CHRM4 | |
| SCHEMBL21500436 | 0.86 | PIK3CD (0.40) | SMN1; SMN2CYP2D6CYP2C9CHRM2CHRM4 | |
| SCHEMBL23641748 | 0.82 | SMN1; SMN2 (0.36) | SMN1; SMN2CYP2D6CYP2C9CHRM2CHRM4 | |
| SCHEMBL508753 | 0.82 | SMN1; SMN2 (0.36) | SMN1; SMN2CYP2D6CYP2C9CHRM2CHRM4 | |
| SCHEMBL11588860 | 0.82 | MEN1 (0.36) | SMN1; SMN2CYP2D6CYP2C9CHRM2CHRM4 | |
| SCHEMBL6956406 | 0.81 | — | — | |
| SCHEMBL10644061 | 0.79 | CHRM2 (0.38) | SMN1; SMN2CYP2D6CYP2C9CHRM2CHRM4 | |
| SCHEMBL22372501 | 0.77 | CHRM2 (0.37) | SMN1; SMN2CYP2D6CYP2C9CHRM2CHRM4 | |
| SCHEMBL1536266 | 0.77 | CHRM2 (0.37) | SMN1; SMN2CYP2D6CYP2C9CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119421882-A | FGFR2 inhibitor compounds | 伊莱利利公司 | 2025-02-11 | — | — | CN | disclosed |
| US-20240243359-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERIES AND RECHARGEABLE LITHIUM BATTERIES | SAMSUNG SDI CO., LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20240243359-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERIES AND RECHARGEABLE LITHIUM BATTERIES | SAMSUNG SDI CO., LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20240238430-A1 | ANTI-CEA IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. (US) | 2024-07-18 | — | — | US | disclosed |
| EP-4394973-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERIES AND RECHARGEABLE LITHIUM BATTERIES | Samsung SDI Co., Ltd. (KR) | 2024-07-03 | — | — | EP | disclosed |
| US-12018029-B2 | Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2024-06-25 | — | — | US | disclosed |
| US-12018029-B2 | Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2024-06-25 | — | — | US | disclosed |
| US-11912713-B2 | 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same | TREVENA, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-11912713-B2 | 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same | TREVENA, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-11913071-B2 | Methods and compositions for sequencing complementary polynucleotides | Singular Genomics Systems, Inc. (US) | 2024-02-27 | — | — | US | disclosed |
| EP-0115304-A2 | Silver halide multi-layered color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1984-08-08 | — | — | EP | disclosed |
| EP-0114675-A2 | Color photographic silver halide light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1984-08-01 | — | — | EP | disclosed |
| EP-0096873-A2 | Silver halide color photographic light-sensitive materials | FUJI PHOTO FILM CO., LTD. (JP) | 1983-12-28 | — | — | EP | disclosed |
| US-4293691-A | Method for preparing magenta couplers having thioether groups | FUJI PHOTO FILM CO., LTD. (JP) | 1981-10-06 | — | — | US | disclosed |
| US-4283486-A | DISCOLORATION INHIBITION | FUJI PHOTO FILM CO., LTD. (JP) | 1981-08-11 | — | — | US | disclosed |
| US-4266019-A | HETEROCYCLIC SUBSTITUTED AMIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1981-05-05 | — | — | US | disclosed |
| US-4146396-A | TWO EQUIVALENT COUPLER | FUJI PHOTO FILM CO., LTD. (JP) | 1979-03-27 | — | — | US | disclosed |
| US-4022620-A | SILVER HALIDE, AMINE | FUJI PHOTO FILM CO., LTD. (JA) | 1977-05-10 | — | — | US | disclosed |
| US-4012259-A | DICARBONYL METHYLENE GROUP ON A 2,5-DIOXO-1-IMIDAZOLIDINE IS A YELLOW COUPLER | FUJI PHOTO FILM CO., LTD. (JA) | 1977-03-15 | — | — | US | disclosed |
| US-3990896-A | YELLOW COLOR FORMING COUPLERS WITH 5-ALKYLIDINE-3-HYDANTOINYL GROUPS | FUJI PHOTO FILM CO., LTD. (JA) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238430-A1 | ANTI-CEA IMMUNOCONJUGATES, AND USES THEREOF | CA14, CA12, CA13 | SMN1; SMN2 4719/4885CYP2D6 879/4885CYP2C9 401/4885 |
| US-12018029-B2 | Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors | LOX, LOXL1, LOXL3 | SMN1; SMN2 3383/4885CYP2D6 231/4885CYP2C9 378/4885 |
| US-11912713-B2 | 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same | OPRD1, OPRM1, OPRK1 | SMN1; SMN2 989/4885CYP2D6 500/4885CYP2C9 658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.